skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 7
Patent #:
6312602
Issue Dt:
11/06/2001
Application #:
09212174
Filing Dt:
12/15/1998
Inventor:
BONAWENTURA KOCHEL
Title:
PEPTIDE-CONTAINING COMPOSITIONS, AND METHODS OF MAKING AND USING SAME
Assignment: 1
Reel/Frame:
013138/0284Recorded: 07/29/2002Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
IMMUNE MODULATION MAXIMUM CORPORATION
Exec Dt:
07/11/2002
Assignee:
ADVANCED VIRAL RESEARCH CORP.
200 CORPORATE BLVD. SOUTH
YONKERS, NEW YORK 10701
Correspondent:
COHEN, PONTANI, LIEBERMAN & PAVANE
YUNLING REN
551 FIFTH AVENUE, 12TH FLOOR
NEW YORK, NEW YORK 10176
Assignment: 2
Reel/Frame:
016377/0563Recorded: 03/21/2005Pages: 23
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
COMMONWEALTH PHARMACEUTICALS, LTD.
Exec Dt:
03/15/2005
MODULATION MAXIMUM CORP.
Exec Dt:
03/15/2005
MILLER, CHARLES E.
Exec Dt:
03/15/2005
Assignee:
ADVANCED VIRAL RESEARCH CORP.
200 CORPORATE BOULEVARD SOUTH
YONKERS, NEW YORK 10701
Correspondent:
MYRON COHEN
COHEN, PONTANI, LIEBERMAN & PAVANE
551 FIFTH AVENUE, 12TH FLOOR
NEW YORK, NY 10176
Assignment: 3
Reel/Frame:
022510/0187Recorded: 04/06/2009Pages: 86
Conveyance:
FORECLOSURE BY THIRD PARTY
Assignor:
YA GLOBAL INVESTMENTS, L.P. (F/K/A CORNELL CAPITAL PARTNERS, L.P.)
Exec Dt:
03/18/2009
Assignees:
ADVANCED VIRAL RESEARCH CORP.
200 CORPORATE BOULEVARD SOUTH
YONKERS, NEW YORK 10701
TRIAD BIOTHERAPEUTICS, INC.
200 CORPORATE BOULEVARD SOUTH
YONKERS, NEW YORK 10701
Correspondent:
LAWRENCE H. MEIER
199 MAIN STREET
BURLINGTON, VT 05401
Assignment: 4
Reel/Frame:
022542/0001Recorded: 04/14/2009Pages: 89
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR/ASSIGNEE NAMES PREVIOUSLY RECORDED ON REEL 022510 FRAME 0187. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNORS ARE ADVANCED VIRAL RESEARCH CORP. AND TRIAD BIOTHERAPEUTICS, INC., AND THE ASSIGNEE IS YA GLOBAL INVESTMENTS, L.P.
Assignors:
ADVANCED VIRAL RESEARCH CORP.
Exec Dt:
03/18/2009
TRIAD BIOTHERAPEUTICS, INC.
Exec Dt:
03/18/2009
Assignee:
YA GLOBAL INVESTMENTS, L.P. (F/K/A CORNELL CAPITAL PARTNERS, L.P.)
101 HUDSON STREET, SUITE 3700
JERSEY CITY, NEW JERSEY 07302
Correspondent:
LAWRENCE H. MEIER
199 MAIN STREET
BURLINGTON, VT 05401
Assignment: 5
Reel/Frame:
022629/0569Recorded: 04/30/2009Pages: 89
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY PREVIOUSLY RECORDED ON REEL 022542 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE OWNERSHIP TRANSFERED FROM ADVANCED VIRAL RESEARCH CORP. AND TRIAD BIOTHERAPEUTICS, INC. TO BBM HOLDINGS, INC.
Assignors:
ADVANCED VIRAL RESEARCH CORP.
Exec Dt:
03/18/2009
TRIAD BIOTHERAPEUTICS, INC.
Exec Dt:
03/18/2009
Assignee:
BBM HOLDINGS, INC.
1245 BRICKYARD ROAD #590
SALT LAKE CITY, UTAH 84106
Correspondent:
LAWRENCE H. MEIER
199 MAIN STREET
BURLINGTON, VT 05401
Assignment: 6
Reel/Frame:
022708/0679Recorded: 05/20/2009Pages: 9
Conveyance:
SECURITY AGREEMENT
Assignor:
BBM HOLDINGS, INC.
Exec Dt:
03/18/2009
Assignee:
YA GLOBAL INVESTMENTS, L.P.
101 HUDSON STREET, SUITE 3700
JERSEY CITY, NEW JERSEY 07302
Correspondent:
JAMIE T. GALLAGHER, ESQ.
199 MAIN STREET
BURLINGTON, VT 05401
Assignment: 7
Reel/Frame:
030213/0442Recorded: 04/15/2013Pages: 8
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
BBM HOLDINGS, INC.
Exec Dt:
08/04/2009
Assignee:
OHR PHARMACEUTICAL, INC.
489 FIFTH AVENUE, 28TH FLOOR
NEW YORK, NEW YORK 10017
Correspondent:
JAMIE T. GALLAGHER, ESQ.
199 MAIN STREET
BURLINGTON, VT 05401

Search Results as of: 05/06/2024 05:18 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT